NASDAQ OMX

Nasdaq to Acquire Sybenetix

Dela

The acquisition of Sybenetix will further expand Nasdaq's leadership in the surveillance space and make it a leading provider to the buy-side industry

NEW YORK & LONDON, July 25, 2017 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) today announced that it has entered into a definitive agreement to acquire Sybenetix, a leading surveillance provider that combines behavioral analytics and cognitive computing with financial markets expertise. Sybenetix's technology offering is designed to solve key surveillance challenges facing the asset management industry.  

The addition of Sybenetix to Nasdaq's Risk & Surveillance suite of solutions, including SMARTS and TradeGuard, will allow Nasdaq to bring deeper technology savviness and expertise to buy-side compliance officers across the global capital markets who require future-focused surveillance capabilities to protect their firms. Sybenetix's behavioral science technology will further strengthen Nasdaq's conduct surveillance offering, which will provide a holistic view of behavioral risks across trade, ecomms, acomms, and other monitoring and surveillance functions. This will also help support compliance departments in addressing complex regulations and policies-both current and on the horizon-such as MAR, MiFID II, Dodd-Frank, Regulation Automated Trading, trader conduct & remuneration, personal account dealing and fair investment allocation.

"Nasdaq is investing in the technologies, talent and capabilities that solve the complex challenges our clients face," said Adena Friedman, President and CEO of Nasdaq. "We believe behavioral science, cognitive computing and machine intelligence are essential to a successful, holistic surveillance offering and critical to efficient and effective organizational compliance with an increasingly intricate global regulatory environment. As such, we are thrilled to welcome the talented technology team and clients from Sybenetix. Their bespoke compliance, surveillance and performance management technology can meet the needs of the world's largest asset managers and will be complementary to Nasdaq's Risk and Surveillance suite. This acquisition accelerates our offering to the buy-side and advances our ambitions to expand market integrity controls into all segments of the capital markets."

Taras Chaban, CEO and Wendy Jephson, Chief Behavioral Scientist, the Founders of Sybenetix, said: "We are extremely proud to be joining Nasdaq. This acquisition is recognition of the talent, innovation and hard work of the Sybenetix team. Being part of Nasdaq will provide enormous growth opportunities for Sybenetix's surveillance technologies and will also accelerate new product development for the buy-side industry. Our clients will benefit from the added confidence of working with a world-leading company that understands the business and requirements of Sybenetix's buy-side customers. We believe this is an incredible opportunity and are looking forward to working with the Nasdaq team."

As the industry benchmark for real-time and T+1 cross-market surveillance platforms, Nasdaq's SMARTS surveillance technology automates the detection, investigation and analysis of potentially abusive or disorderly trading, to help improve the overall efficiency of the surveillance organization and reduce cost, even as market complexity and new regulations increase. These solutions are used to power monitoring for more than 45 marketplaces, 17 regulators and 140+ market participants, including several buy-side institutions, across 65 countries, while Nasdaq's market technology, including trading, clearing, and CSD systems, is in operation in over 100 marketplaces across the Americas, Europe, Asia, Australia, Africa, the Middle East and the Caribbean.

Nasdaq will acquire Sybenetix for an undisclosed amount and intends to fund the purchase price with cash on hand. Nasdaq does not expect the acquisition to have a material impact on Nasdaq's financial leverage or capital return strategy, and is expected to generate attractive returns on capital.

About Nasdaq

Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com.

About Sybenetix

Sybenetix is a leading behavioural analytics company, providing the next-level category of advanced analytics being used by major financial institutions for market surveillance, conduct risk measurement and performance improvement.  Sybenetix's unique team of experts in technology, behavioural science, financial performance and conduct management have been recognised through multiple industry awards for improved business outcomes for their customers. Sybenetix's technology allows clients to improve regulatory, reputational and operational effectiveness whilst dramatically reducing costs. Sybenetix is headquartered in London, United Kingdom and is backed by leading Fintech and Regtech investors Summer Capital, Collinio Capital and Yarrow Capital. http://sybenetix.com

Cautionary Note Regarding Forward-Looking Statements 
Information set forth in this communication contains forward-looking statements that involve a number of risks and uncertainties.  Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information.  Such forward-looking statements include, but are not limited to (i) projections relating to our future financial results, total shareholder returns, growth, trading volumes, products and services, order backlog, taxes and achievement of synergy targets, including in connection with the acquisition of Sybenetix, (ii) statements about the closing or implementation dates and benefits of the acquisition of Sybenetix, (iii) statements about our integrations of our recent acquisitions and future integration of the Sybenetix acquisition, (iv) statements relating to any litigation or regulatory or government investigation or action to which we are or could become a party, and (v) other statements that are not historical facts.  Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control.  These factors include, but are not limited to, Nasdaq's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors detailed in Nasdaq's filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q, which are available on Nasdaq's investor relations website at http://ir.nasdaq.com and the SEC's website at www.sec.gov.  Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

NDAQG

For Media Inquiries:

Nasdaq
Ryan Wells
ryan.wells@nasdaq.com
Direct: +44 (0) 20 3753 2231
Mobile:  +44 (0) 7809 596 390




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nasdaq via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering25.5.2018 16:38Pressmeddelande

Jacobs, one of the world's largest engineering and environmental consultancy groups, has more than 70,000 employees globally SYDNEY, Australia and MINNEAPOLIS, May 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio's Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions. Through the Mental Health Check-In, companies can offer employees an end-to-end mental health program, direct to their devices, to see how the mind and body are tracking. It's a personalized, private, and objective way to see the unseeable: mental health issues in the workplace. Employees are provided the opportunity to confidentially check-in on their mental health and receive personalized confidential results from both an objective biometric screening in conjunction with a 12-minute subjective survey. Employers receive

LeoVegas warms up ahead of FIFA World Cup with launch of sportsbook 2.0 and new design25.5.2018 14:20Pressmeddelande

LeoVegas is conducting constant development to further improve the gaming experience with the launch of sportsbook 2.0 and a new design for Leovegas.com. It strengthens LeoVegas mobile position and increases the competitiveness within sports betting. "Our new design has been created to give our customers a better overview of all games in all product verticals," comments Gustaf Hagman, CEO of LeoVegas. "The design features a simplified and more intuitive experience, which is especially important in sport, where relevance and simplicity are key factors. On top of this we are launching a number of updates and expanding ownership of the sportsbook. Together this builds further on creating a world class gaming experience and is in line with our passion "Leading the way into the mobile future". This will give us the right conditions ahead of the World Cup, but it also represents a long-term springboard towards building the world's best mobile sportsbook". Improved sports betting experience L

LeoVegas värmer upp inför fotbolls VM och lanserar sportbok 2.0 med ny design25.5.2018 14:19Pressmeddelande

Det sker en ständig utveckling av LeoVegas och för att förbättra spelupplevelsen ytterligare lanseras nu sportbok 2.0 samt en ny design av LeoVegas.com. Det stärker LeoVegas mobila position och ökar konkurrenskraften inom sportsbetting. "Vår nya design är skapad för att ge våra kunder en bättre överblick för alla spel inom samtliga produktvertikaler. Designen ger en förenklad och mer intuitiv upplevelse vilket är särskilt viktigt inom sport där relevans och enkelhet är nyckelfaktorer. Utöver det lanserar vi ett flertal uppdateringar samt ökar ägarskapet av sportboken. Tillsammans bygger det vidare på att skapa en spelupplevelse i världsklass och går i linje med vår passion "Leading the way to the mobile future". Detta ger oss rätt förutsättningar inför VM men de är också ett långsiktigt avstamp till att bygga världens bästa mobila sportbok. säger Gustaf Hagman, CEO LeoVegas. Förbättrad sportupplevelse LeoVegas har nu ägarskap över flera sidor som leverantören Kambi tidigare hade kontro

VIRGIN PULSE ANNOUNCES INDUSTRY-LEADING GDPR COMPLIANCE25.5.2018 14:00Pressmeddelande

Virgin Pulse Extends the GDPR's Strong Data Privacy Rights to All Clients and Members Across the Globe PROVIDENCE, R.I., May 25, 2018 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of digital employee health, wellbeing and engagement solutions, today announced that it has achieved compliance with the EU General Data Protection Regulation (GDPR) for the Virgin Pulse platform. The company has also appointed Associate Counsel Beatrice Botti as Data Protection Officer (DPO) to oversee the Virgin Pulse privacy program. With this achievement, Virgin Pulse leads the market as the first company in the wellbeing and engagement industry to fully meet the comprehensive standards of the new GDPR data privacy law. The company has completed a thorough review of its internal data collection, storage and handling processes and implemented enhancements to achieve GDPR compliance and give all Virgin Pulse customers and members greater control over their personal data. The GDPR is the firs

Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45Pressmeddelande

CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressmeddelande

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum